InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 16:09
InflaRx Gross Profit (Quarterly): -0.2004M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.2004M |
| December 31, 2023 | -0.296M |
| September 30, 2023 | -0.2116M |
| June 30, 2023 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.296M
Minimum
Dec 2023
--
Maximum
Sep 2022
-0.118M
Average
-0.1002M
Median
Gross Profit (Quarterly) Benchmarks
| Affimed NV | -- |
| MorphoSys AG | 47.84M |
| BioNTech SE | 139.58M |
| Immatics NV | -- |
| CureVac NV | -33.42M |